Rijavithi Viral and Mycobacterium PCR Arrays in CNS Infection Study
NCT00807378 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2010-05-20
Summary
This study of neurotropic viral infection and Tuberculous CNS infection is the comprehensive investigation of CSF PCR arrays (Hybrydiaztion technique,Sybergreen and Taqman real time PCR arrays of CSF ) in suspected cases of viral CNS infection, Tuberculous CNS infection in both AIDS and non AIDS patients.
Patients with clinical viral encephalitis and all meningoencephalitis including all patients with HIV/AIDS CSF and non AIDS will be banked and test for RNA and DNA viral sequence by Real time PCR arrays and IS6110 gene of Mycobacterium tuberculosis. Clinical data and final diagnosis will be used to analyze the result of this PCR arrays technique compared to clinical gold standard criteria.
Conditions
- CNS Viral Infection
Interventions
- OTHER
-
LUMBAR PUNCTURE
LUMBAR PUNCTURE FFOR CSF COLLECTION
Sponsors & Collaborators
-
Rajavithi Biomolecular Research Center
collaborator OTHER -
Department of Medical Services Ministry of Public Health of Thailand
lead OTHER_GOV
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2009-12-31
- Completion
- 2010-03-31
More Related Trials
-
A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies
NCT00006072 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)
NCT00701662 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders
NCT05136976 ·Status: RECRUITING ·Phase: PHASE3
-
Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders
NCT06068829 ·Status: UNKNOWN
-
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
NCT01613599 ·Status: COMPLETED
-
Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis
NCT05177939 ·Status: UNKNOWN ·Phase: PHASE3
-
Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
NCT06169150 ·Status: RECRUITING
-
Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
NCT06452537 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Low-dose Rituximab in the Treatment of Refractory Myasthenia Gravis
NCT05332587 ·Status: UNKNOWN ·Phase: PHASE3
-
A Pilot Trial of Rituxan in Refractory Myasthenia Gravis
NCT00619671 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis
NCT07039578 ·Status: RECRUITING ·Phase: PHASE2
-
A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis
NCT02115997 ·Status: COMPLETED ·Phase: PHASE4
-
Meningococcal Vaccination in Patients on Complement Inhibitors
NCT06906692 ·Status: ACTIVE_NOT_RECRUITING
-
Natalizumab High Titer Immunogenicity and Safety
NCT00516893 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms
NCT00487708 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
NCT00774462 ·Status: COMPLETED ·Phase: PHASE2
-
MEmbranous Nephropathy Trial Of Rituximab
NCT01180036 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Anti-CGRP for Inflammation and Pain Modulation in Small Fiber Neuropathy/Fibromyalgia
NCT04158752 ·Status: COMPLETED ·Phase: PHASE4
-
Neuropathy and Anti-GFAP Antibodies
NCT05742087 ·Status: UNKNOWN
-
Efficacy of Vaccination Against COVID-19 in Patients Presenting a Neuromuscular Disease With Severe Amyotrophy
NCT05353738 ·Status: COMPLETED
-
Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
NCT01626248 ·Status: COMPLETED
-
An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients
NCT05356858 ·Status: TERMINATED ·Phase: PHASE2
-
Rituximab for the Treatment of New-onset AChR-Myasthenia Gravis
NCT07071246 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
GC012F in Patients With Autoimmune Diseases
NCT07072884 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
A Study of Anti-IL-6R mAb Injection in Patients With iMCD
NCT05345522 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2